Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Randomized, Double-blind, Phase IV Clinical Trial on the Diuretic Effects of Acetazolamide in Patients With Decompensated Heart Failure and Volume OveRload

NCT03505788 is registered in ClinicalTrials.gov with Ziekenhuis Oost-Limburg as lead sponsor.

NCT NCT03505788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03505788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Randomized, Double-blind, Phase IV Clinical Trial on the Diuretic Effects of Acetazolamide in Patients With Decompensated Heart Failure and Volume OveRload
Lead sponsor
Ziekenhuis Oost-Limburg
Phase
Phase 4
Overall status
Completed
Start date
November 11, 2018
Completion date
May 16, 2022
Enrollment
519 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute decompensated heart failure, volume overload